1. Home
  2. CIX vs ATAI Comparison

CIX vs ATAI Comparison

Compare CIX & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CompX International Inc.

CIX

CompX International Inc.

HOLD

Current Price

$37.02

Market Cap

473.6M

ML Signal

HOLD

Logo ATAI Life Sciences N.V.

ATAI

ATAI Life Sciences N.V.

HOLD

Current Price

$7.34

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CIX
ATAI
Founded
1993
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
473.6M
2.7B
IPO Year
1997
2025

Fundamental Metrics

Financial Performance
Metric
CIX
ATAI
Price
$37.02
$7.34
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$15.88
AVG Volume (30 Days)
15.8K
14.0M
Earning Date
05-05-2026
05-11-2026
Dividend Yield
9.48%
N/A
EPS Growth
17.04
N/A
EPS
1.06
N/A
Revenue
$158,285,000.00
$4,089,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$35.61
N/A
Revenue Growth
8.46
1227.60
52 Week Low
$20.29
$3.27
52 Week High
$40.29
$7.45

Technical Indicators

Market Signals
Indicator
CIX
ATAI
Relative Strength Index (RSI) 70.01 62.24
Support Level $23.33 $3.32
Resistance Level N/A N/A
Average True Range (ATR) 2.63 0.08
MACD 0.21 -0.05
Stochastic Oscillator 86.34 50.23

Price Performance

Historical Comparison
CIX
ATAI

About CIX CompX International Inc.

Compx International Inc is a manufacturer of security products. Its security products are used in recreational transportation, postal, office & institutional furniture, cabinetry, tool storage, healthcare, and a variety of other industries. Also, it is engaged in the manufacturing of stainless steel exhaust systems, gauges, throttle controls, and trim tabs for the recreational marine industry. The company's reportable operating segment includes Security Products and Marine Components. It generates maximum revenue from the Security Products segment, which manufactures mechanical and electrical cabinet locks and other locking mechanisms. Geographically, the company generates maximum revenue from the United States, followed by Canada, Mexico, and other markets.

About ATAI ATAI Life Sciences N.V.

AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD, and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.

Share on Social Networks: